Prescription drug · ANDA
Divalproex sodium NDC 71335-1883
Divalproex sodium 500 mg/1 · Tablet, Extended release · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-1883-1 | 71335188301 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1883-1)Marketed from Jul 18, 2024 | |
| 71335-1883-2 | 71335188302 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1883-2)Marketed from Jun 21, 2021 | |
| 71335-1883-3 | 71335188303 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1883-3)Marketed from Aug 18, 2022 | |
| 71335-1883-4 | 71335188304 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1883-4)Marketed from Aug 18, 2022 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Divalproex sodium
- Generic name (nonproprietary)
- divalproex sodium
- Active ingredients
- Divalproex sodium — 500 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 209286
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
- Identifiers
- Product ID 71335-1883_6dcd8d8d-3860-46c8-a8dd-3003604bc821SPL ID 6dcd8d8d-3860-46c8-a8dd-3003604bc821SPL set ID 0822300b-68c0-4e70-b1ba-8eb42cf373f7RxCUI 1099569UNII 644VL95AO6
- Pharmacologic class
- Anti-epileptic Agent; Mood Stabilizer
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335188301followed by a unit qualifier and the quantityPackage 71335-1883-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.
Other NDCs under ANDA 209286
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Divalproex sodium | Divalproex sodium 250 mg/1 | Tablet, Extended releaseOral | PD-Rx Pharmaceuticals, Inc. | 72789-286 |
| Divalproex sodium | Divalproex sodium 250 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-3183 |
| Divalproex Sodium ER | Divalproex sodium 500 mg/1 | Tablet, Extended releaseOral | Direct_Rx | 72189-459 |
| Divalproex sodium | Divalproex sodium 250 mg/1 | Tablet, Extended releaseOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8376 |
| Divalproex sodium | Divalproex sodium 500 mg/1 | Tablet, Extended releaseOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8377 |
| Divalproex sodium | Divalproex sodium 250 mg/1 | Tablet, Extended releaseOral | Lupin Pharmaceuticals, Inc. | 68180-260 |
| Divalproex sodium | Divalproex sodium 500 mg/1 | Tablet, Extended releaseOral | Lupin Pharmaceuticals, Inc. | 68180-261 |
| Divalproex sodium | Divalproex sodium 500 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-3477 |
| Divalproex sodium | Divalproex sodium 500 mg/1 | Tablet, Extended releaseOral | Preferred Pharmaceuticals, Inc. | 68788-8358 |